Does KCNE5 play a role in long QT syndrome?

Background: Long QT syndrome [LQTS] is a congenital cardiac disease characterised by prolonged QTC-time, syncopes and sudden cardiac death. LQTS is caused by mutations in genes coding for ion channels involved in the action potential. KCNE5 codes for a novel β-subunit of the ion channel conducting t...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinica chimica acta 2004-07, Vol.345 (1), p.49-53
Hauptverfasser: Hofman-Bang, Jacob, Jespersen, Thomas, Grunnet, Morten, Larsen, Lars Allan, Andersen, Paal Skytt, Kanters, Jørgen Kim, Kjeldsen, Keld, Christiansen, Michael
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background: Long QT syndrome [LQTS] is a congenital cardiac disease characterised by prolonged QTC-time, syncopes and sudden cardiac death. LQTS is caused by mutations in genes coding for ion channels involved in the action potential. KCNE5 codes for a novel β-subunit of the ion channel conducting the delayed rectifier repolarizing current I Ks. As KCNE5 is expressed in the human heart and suppresses the I Ks current in heterologous systems, it is a candidate gene that may be mutated in LQTS families where no causative mutations in known LQTS associated genes have been found. We examined whether this was the case. Methods: Genomic DNA from LQTS patients [ n=88] and normal controls [ n=90] was screened for mutations in KCNE5 by endonuclease-enhanced single strand conformation polymorphism analysis [EE-SSCP], and DNA sequencing of aberrant conformers. Mutations in other LQTS associated ion channels were excluded by SSCP. Results: No mutations were found in the coding region of the KCNE5 gene in LQTS patients. One polymorphism, a T-to-C transition at nucleotide 97, causing an amino acid polymorphism P33S, was present in 16 persons, nine heterozygotes and seven homozygotes. The T-allele frequency was 0.13 in LQTS patients and 0.10 in controls.
ISSN:0009-8981
1873-3492
DOI:10.1016/j.cccn.2004.02.033